secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2026-05-29T20:13:38+00:00
Accession:  0001493152-26-026364
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric shareholders approve reverse stock split, reject increase in authorized shares
--------------------------------------------------------------------------------

- Reverse stock split (1:5 to 1:15) approved: 793,344 for, 190,175 against, 8,309 abstentions.
- Authorized share increase to 5B shares rejected: 427,158 for, 555,147 against, 9,523 abstentions.
- Six director nominees elected: Michael Webb, George Kegler, Frank Pasqualone, Marcus Schabacker, Joseph Tucker, Sheila DeWitt.
- Say-on-pay advisory vote passed: 569,552 for, 26,884 against, 5,297 abstentions.
- Ratification of CBIZ CPAs as auditor passed: 960,728 for, 19,347 against, 11,753 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315226026364/0001493152-26-026364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315226026364/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer